Cargando…

Doxycycline reduces osteopenia in female rats

Doxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in b...

Descripción completa

Detalles Bibliográficos
Autores principales: de Figueiredo, Fellipe A. T., Shimano, Roberta C., Ervolino, Edilson, Pitol, Dimitrius L., Gerlach, Raquel F., Issa, Joao Paulo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814740/
https://www.ncbi.nlm.nih.gov/pubmed/31653893
http://dx.doi.org/10.1038/s41598-019-51702-y
_version_ 1783463044776460288
author de Figueiredo, Fellipe A. T.
Shimano, Roberta C.
Ervolino, Edilson
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
author_facet de Figueiredo, Fellipe A. T.
Shimano, Roberta C.
Ervolino, Edilson
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
author_sort de Figueiredo, Fellipe A. T.
collection PubMed
description Doxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in bone remodeling. The main objective of this study was to evaluate the action of the drug doxycycline in the control of osteopenia. Sixty three Wistars rats were divided into 9 groups with n = 7 each, as follow: the control group with doxycycline 10 mg/kg/day (C10), control with doxycycline 30 mg/kg/day (C30) and control (C), ovariectomized group with doxycycline 10 mg/kg/day (OVX10), ovariectomized with doxycycline 30 mg/kg/day (OVX30), and ovariectomized with water (OVX), sedentary group with 10 mg/kg/day (Se10), sedentary with doxycycline 30 mg/kg/day (Se30), and sedentary group with water (Se). Left femoral bone was used for bone densitometry, right femoral bone for histological analysis. The right tibia was intended for chemical quantifications, the total serum was used for cholesterol and calcium quantification. The length of the left femoral bone was measured after the densitometry analysis. Statistical analysis was performed using multivariate general linear model (ANOVA two factors with Bonferroni adjustment) and the TRAP analysis was subjected to normality test and then were subjected to nonparametric test, both with p < 0.05 significance. Statistically significant differences were found, with better results for the groups exposed to the medication (10 and 30 mg/kg/day): Se vs. Se10 and Se vs. Se30 for BMC, quantification of magnesium, amount of cancellous bone in the distal portion; OVX vs. OVX10 for BMC, BMD and calcium in serum; OVX vs. OVX10 and OVX30 for quantification in proximal and distal portion of cancellous bone; Se vs. Se30 and OVX vs. OVX30 for immunostaining for TRAP, all results with minimum of p ≤ 0.05. Doxycycline had a deleterious effect on control groups and positive action for bone organization on female rats affected by bilateral ovariectomy-induced osteopenia and sedentary lifestyle.
format Online
Article
Text
id pubmed-6814740
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68147402019-10-30 Doxycycline reduces osteopenia in female rats de Figueiredo, Fellipe A. T. Shimano, Roberta C. Ervolino, Edilson Pitol, Dimitrius L. Gerlach, Raquel F. Issa, Joao Paulo M. Sci Rep Article Doxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in bone remodeling. The main objective of this study was to evaluate the action of the drug doxycycline in the control of osteopenia. Sixty three Wistars rats were divided into 9 groups with n = 7 each, as follow: the control group with doxycycline 10 mg/kg/day (C10), control with doxycycline 30 mg/kg/day (C30) and control (C), ovariectomized group with doxycycline 10 mg/kg/day (OVX10), ovariectomized with doxycycline 30 mg/kg/day (OVX30), and ovariectomized with water (OVX), sedentary group with 10 mg/kg/day (Se10), sedentary with doxycycline 30 mg/kg/day (Se30), and sedentary group with water (Se). Left femoral bone was used for bone densitometry, right femoral bone for histological analysis. The right tibia was intended for chemical quantifications, the total serum was used for cholesterol and calcium quantification. The length of the left femoral bone was measured after the densitometry analysis. Statistical analysis was performed using multivariate general linear model (ANOVA two factors with Bonferroni adjustment) and the TRAP analysis was subjected to normality test and then were subjected to nonparametric test, both with p < 0.05 significance. Statistically significant differences were found, with better results for the groups exposed to the medication (10 and 30 mg/kg/day): Se vs. Se10 and Se vs. Se30 for BMC, quantification of magnesium, amount of cancellous bone in the distal portion; OVX vs. OVX10 for BMC, BMD and calcium in serum; OVX vs. OVX10 and OVX30 for quantification in proximal and distal portion of cancellous bone; Se vs. Se30 and OVX vs. OVX30 for immunostaining for TRAP, all results with minimum of p ≤ 0.05. Doxycycline had a deleterious effect on control groups and positive action for bone organization on female rats affected by bilateral ovariectomy-induced osteopenia and sedentary lifestyle. Nature Publishing Group UK 2019-10-25 /pmc/articles/PMC6814740/ /pubmed/31653893 http://dx.doi.org/10.1038/s41598-019-51702-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
de Figueiredo, Fellipe A. T.
Shimano, Roberta C.
Ervolino, Edilson
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
Doxycycline reduces osteopenia in female rats
title Doxycycline reduces osteopenia in female rats
title_full Doxycycline reduces osteopenia in female rats
title_fullStr Doxycycline reduces osteopenia in female rats
title_full_unstemmed Doxycycline reduces osteopenia in female rats
title_short Doxycycline reduces osteopenia in female rats
title_sort doxycycline reduces osteopenia in female rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814740/
https://www.ncbi.nlm.nih.gov/pubmed/31653893
http://dx.doi.org/10.1038/s41598-019-51702-y
work_keys_str_mv AT defigueiredofellipeat doxycyclinereducesosteopeniainfemalerats
AT shimanorobertac doxycyclinereducesosteopeniainfemalerats
AT ervolinoedilson doxycyclinereducesosteopeniainfemalerats
AT pitoldimitriusl doxycyclinereducesosteopeniainfemalerats
AT gerlachraquelf doxycyclinereducesosteopeniainfemalerats
AT issajoaopaulom doxycyclinereducesosteopeniainfemalerats